Vanda Pharmaceuticals Company IP News and Updates

  In late October, we unveiled the CAFC Intelligence Report 2023, a comprehensive analysis encompassing stakeholders before the Court of...

Last month, we released our third annual ANDA Litigation Intelligence Report evaluating all stakeholders in ANDA/Hatch-Waxman cases filed over the...

Earlier this year, the Supreme Court issued orders to the Solicitor General to weigh in on whether or not the...

I have posted twice recently on the Fed. Cir.’s opinion in Vanda Pharms., Inc. v. West-Ward Pharm. Int’l, Ltd., Appeal...

CASE OF THE WEEK Vanda Pharm. Inc. v. West-Ward Pharm. Int’l Ltd. et al., Appeal Nos. 16-2707, 16-2708 (Fed. Cir....